View More Recent Stories
-
Fortrea (FTRE) PT Lowered to $20 at TD Cowen
-
Citi Downgrades Fortrea (FTRE) to Neutral
-
Baird Downgrades Fortrea (FTRE) to Neutral
-
Fortrea (FTRE) PT Lowered to $28 at Baird
-
Fortrea (FTRE) PT Raised to $25 at TD Cowen
-
Fortrea (FTRE) PT Raised to $25 at Barclays
-
Activist Investor Corvex Builds Position in Fortrea (FTRE) - Bloomberg
-
Investors should cut exposure to CROs as biotech market slows: Jefferies
-
Jefferies Downgrades Fortrea (FTRE) to Hold
-
Fortrea (FTRE) PT Lowered to $23 at Deutsche Bank
-
Fortrea (FTRE) PT Lowered to $23 at TD Cowen
-
Fortrea (FTRE) PT Lowered to $22 at Mizuho
-
Fortrea (FTRE) PT Lowered to $30 at Citi
-
Fortrea (FTRE) PT Lowered to $22 at Evercore ISI
-
FTRE (FTRE) Misses Q2 EPS by 27c ; Offers Guidance
-
Evercore ISI Downgrades Fortrea (FTRE) to In Line
-
Fortrea (FTRE) August and December 35 calls active
-
Fortrea (FTRE) August 22.50 puts active as share price down 3.6%
-
Fortrea (FTRE) Appoints Robert Parks as Chief Accounting Officer
-
Fortrea (FTRE) Launches AI Innovation Studio

